The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Oct 22, 2026
WS Amati Global Innovation Fund navigated a bifurcated equity market characterized by benchmark index resilience alongside breadth deterioration, with roughly 60% of constituents falling over the quarter despite tech-driven all-time highs in the S&P 500 and NASDAQ. The manager does not report net fund returns or explicit cash weighting figures in the review, but notes that performance was shaped by divergent sector drivers. Negative performance was led by US-listed industrial technology holdings and infrastructure enablers facing cyclical demand worries, while performance was anchored by strong gains across less cyclically sensitive healthcare holdings. The manager observes that rising bond yields reflect a more hawkish inflationary environment fueled by rising energy prices and massive AI capital expenditures, challenges largely impervious to central bank policy levers. While mega-cap technology concentration reached historic extremes—with the top five index holdings comprising approximately 28% and the top ten nearly 40%—breadth softened as market participants questioned the longevity, defensibility, and return profile of frontier AI lab investments. Rather than reacting to short-term cyclical headwinds or geopolitical volatility, the strategy emphasizes structural transformations in industrial automation, electrical grids, and bioprocessing. Portfolio turnover included three new holdings: Dutch-listed defense equipment manufacturer Theon, industrial connectivity specialist Belden, and IT consulting firm CI&T. Meanwhile, the fund maintained existing positions in MKS Instruments, Allegro MicroSystems, and MasTec, viewing market sell-offs across cyclically sensitive innovators as compelling entry points driven by durable multi-year compounding potential rather than broken fundamentals.
Invest in strongly capitalized, structurally advantaged innovation leaders set to benefit from multi-year secular tailwinds in industrial automation, healthcare delivery, and electrical infrastructure build-out regardless of short-term macroeconomic cycles.
Over the next 3 to 5 years, global demand will be shaped by inevitable structural advances in industrial automation, biological pharmaceuticals, and upgraded electrical infrastructure, regardless of shorter-term macroeconomic cycles.
Moderate Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with WS Amati Global Innovation Fund or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.